NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for T-lymphocyte


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response
2009 NOV 23 -- CEL-SCI Corporation (NYSE Amex: CVM) announced that Dr. Kenneth S. Rosenthal, Professor of Immunology and Microbiology of Northeastern Ohio Universities College of Medicine and Pharmacy, reported on work conducted in collaboration with scientists......
Subject: Herpes Simplex
Price: $3.00
*
Data on virology described by researchers at University of Lyon
2009 NOV 23 -- "Up to now, no lentiviral vector (LV) tool existed to govern efficient and stable gene delivery into quiescent B lymphocytes, which hampers its application in gene therapy and immunotherapy areas. Here, we report that LVs incorporating measles......
Subject: Virology
Price: $3.00
*
Findings from M. Malphettes and co-researchers advance knowledge in common variable immunodeficiency
2009 NOV 24 -- According to a study from Paris, France, "Common variable immunodeficiency (CVID) is a primary immune deficiency defined by defective antibody production. In most series, a small proportion of patients present with opportunistic infections......
Subject: Common Variable Immunodeficiency
Price: $3.00
*
Findings in science reported from O. Hayashi and co-researchers
2009 NOV 26 -- According to recent research published in the Journal of Medicinal Food, "We investigated age-related changes in intestinal intraepithelial lymphocyte (IEL) subsets in mice by flow cytometric analysis and their functional preservation as......
Subject: Science
Price: $3.00
*
Investigators at University of Konstanz, Division of Immunology publish new data on post-traumatic stress disorders prevention
2009 NOV 24 -- Fresh data on post-traumatic stress disorders are presented in the report 'Substantial reduction of naive and regulatory T cells following traumatic stress.' According to a study from Konstanz, Germany, "Posttraumatic stress disorder (PTSD) is......
Subject: Post-Traumatic Stress Disorders Prevention
Price: $3.00
*
New genetic cause of a fatal immune disorder
2009 NOV 18 -- Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, fatal, immune disorder characterized by uncontrolled activation of immune cells known as lymphocytes and macrophages. Disease-causing mutations have been identified in several......
Subject: Journal of Clinical Investigation
View Free
Daily News
Article
Reports from University of Brescia describe recent advances in HIV/AIDS
2009 NOV 23 -- "The HIV-1 transactivating factor Tat accumulates on the surface of endothelium by interacting with heparan sulfate proteoglycans (HSPGs). Tat also interacts with B-lymphoid Namalwa cells but only when these overexpress HSPGs after syndecan-1......
Subject: HIV/AIDS
Price: $3.00
*
Reports from W.T. He et al highlight recent research in cardiology
2009 NOV 23 -- According to recent research published in the journal Transplantation, "The involvement of T-cell immunoglobulin mucin-3 (Tim-3) in the regulation of solid organ transplantation rejection is largely unknown. We used galectin-9 (Tim-3 ligand) to......
Subject: Cardiology
Price: $3.00
*
Reports outline applied physiology study findings from X. Li and colleagues
2009 NOV 26 -- "Exposure to microgravity has been implicated in the compromised immune function in space travellers, resulting in opportunistic infections, poor wound healing, and cancer. Since recent studies have suggested that leptin was capable of......
Subject: Applied Physiology
Price: $3.00
*
Research conducted at Brussels Free University has updated our knowledge about diabetes
2009 NOV 23 -- According to recent research published in the journal Diabetes, "The metabolic outcome of islet cell transplants in type 1 diabetic patients is variable. This retrospective analysis examines whether differences in recipient characteristics at......
Subject: Diabetes
Price: $3.00
*
Research from Fourth Military Medical University broadens understanding of life sciences
2009 NOV 23 -- According to recent research from Xian, People's Republic of China, "Optimal T-cell activation requires both an antigen-specific and a costimulatory signal. CD167 is a tyrosine kinase receptor for native type I collagen, its physiologic......
Subject: Life Sciences
Price: $3.00
*
Research on autoimmune disease reported by M.C. Salinascarmona et al
2009 NOV 23 -- According to a study from Monterrey, Mexico, "Infections are frequently associated with immunosuppressive therapy currently used to prevent organ rejection or treat autoimmune diseases. Such drugs suppress antibody production despite having......
Subject: Autoimmune Disease
Price: $3.00
*
Researchers at Wuhan Polytechnic University have published new data on amino acids
2009 NOV 24 -- According to recent research from Wuhan, People's Republic of China, "A study was conducted to investigate the effects of l-arginine (Arg) on performance and immune function in cyclophosphamide (CY) immunosuppressed weaned pigs. The weaned pigs......
Subject: Amino Acids
Price: $3.00
*
Researchers from National Institutes of Health report on findings in cell therapy
2009 NOV 23 -- "A patient with metastatic melanoma who had progressive disease after prior surgical resections, high dose interleukin-2. and anti-cytotoxic T lymphocyte antigen-4 antibody received sequential treatments with autologous tumor infiltrating......
Subject: Cell Therapy
Price: $3.00
*
Researchers from University of Rijeka, Medical Department detail findings in anthropology
2009 NOV 24 -- According to recent research published in the journal Collegium Antropologicum, "The prevalence of environmental diseases is increasing worldwide and these diseases are an onerous burden both to the individual and to the public health. Urban air......
Subject: Anthropology
Price: $3.00
*
Scientists at Third Military Medical University discuss research in immunotherapy
2009 NOV 23 -- "Ran is considered to be a promising target for tumor-specific immunotherapy because its protein is exclusively expressed in tumor tissues, though its mRNA can be expressed in most normal tissues. In our study, we obtained four candidate......
Subject: Immunotherapy
Price: $3.00
*
Scientists at University of Chicago publish research in monoclonal antibodies
2009 NOV 23 -- A report, 'Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence,' is newly published data in Leukemia & Lymphoma. "We......
Subject: Monoclonal Antibodies
Price: $3.00
*
Studies from Can-Fite BioPharma yield new data on arthritis
2009 NOV 23 -- According to recent research from Israel, "Studies have suggested that rheumatoid arthritis (RA) and osteoarthritis (OA) share common characteristics. The highly selective A(3) adenosine receptor agonist CF101 was recently defined as a potent......
Subject: Arthritis
View Free
Daily News
Article
Study data from Fukuoka University provide new insights into non-hodgkin lymphoma risk factors
2009 NOV 23 -- Scientists discuss in 'Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma' new findings in non-hodgkin......
Subject: Non-Hodgkin Lymphoma Risk Factors
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login